- Home
- PIII vs SNES Comparison
PIII vs SNES Comparison
Compare PIII & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- SNES
- Stock Information
- Founded
- PIII 2015
- SNES 2004
- Country
- PIII United States
- SNES United States
- Employees
- PIII N/A
- SNES N/A
- Industry
- PIII Medical/Nursing Services
- SNES Agricultural Chemicals
- Sector
- PIII Health Care
- SNES Industrials
- Exchange
- PIII Nasdaq
- SNES Nasdaq
- Market Cap
- PIII 20.8M
- SNES 21.0M
- IPO Year
- PIII N/A
- SNES 2016
- Fundamental
- Price
- PIII $7.27
- SNES $5.65
- Analyst Decision
- PIII Buy
- SNES Strong Buy
- Analyst Count
- PIII 2
- SNES 1
- Target Price
- PIII $16.25
- SNES $10.00
- AVG Volume (30 Days)
- PIII 4.7K
- SNES 219.4K
- Earning Date
- PIII 08-06-2025
- SNES 08-07-2025
- Dividend Yield
- PIII N/A
- SNES N/A
- EPS Growth
- PIII N/A
- SNES N/A
- EPS
- PIII N/A
- SNES N/A
- Revenue
- PIII $1,485,192,000.00
- SNES $1,927,000.00
- Revenue This Year
- PIII N/A
- SNES $130.53
- Revenue Next Year
- PIII $7.92
- SNES $80.00
- P/E Ratio
- PIII N/A
- SNES N/A
- Revenue Growth
- PIII 9.79
- SNES 40.15
- 52 Week Low
- PIII $6.00
- SNES $1.30
- 52 Week High
- PIII $32.54
- SNES $5.99
- Technical
- Relative Strength Index (RSI)
- PIII 62.71
- SNES 67.74
- Support Level
- PIII $6.30
- SNES $4.31
- Resistance Level
- PIII $7.51
- SNES $5.99
- Average True Range (ATR)
- PIII 0.36
- SNES 0.36
- MACD
- PIII 0.15
- SNES 0.02
- Stochastic Oscillator
- PIII 84.11
- SNES 79.46
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.